Archive: Healthcare
How “Price Gouging” Can Help with the COVID-19 Crisis
When Resources Are Scarce, Price Gouging Can Spur Production, Prevent Hoarding, and Encourage Conservation. But Only if Governments Allow It.
Favor Local Action to Combat the Coronavirus
The government’s tendency to take drastic action and achieve lackluster results suggest that local efforts to mitigate crises might be more successful.
The Cost of Socialism: “Medicare for All” Means Tax Hikes on All
Tax hikes would affect Americans across the socioeconomic spectrum, including those struggling to get by.
There’s a Wrong Way to React to a Drug Shortage—and a Right Way
Expanding bureaucratic control of the drug market which will only put us in a worse position in future crises.
Coping with the Coronavirus Requires Freeing Healthcare Providers
Coronavirus has the potential to expose the serious problems with the US healthcare system.
HSAs Can Save Millions of Smokers’ Lives – with the Right Rules
By leveling the tax playing field, the federal government can give millions of smokers a chance to save their lives.
Are More Vaping Bans Coming Soon? Let’s Hope Not!
To truly “prioritize children, family, and the public health,” we should consider telling the FDA to stop regulating e-cigarettes cold turkey.
Healthcare Sharing Ministries Are a Godsend to More than a Million Patients
HCSMs are far from perfect, but they at least afford patients some incentive to shop around while delivering large, overall premium savings.
As Patients Enter New Decade, Obamacare Remains in the Rear View Mirror
By allowing more choice, policymakers can give patients a chance to enjoy this new year and many more to come.
Thanks to Crony Capitalism, Healthcare Competition Is Flatlining for Consumers
It’s time to end these crony practices and bring back some much-needed competition to the healthcare sector.
Only Markets Can Alleviate Drug Shortages
The most onerous barriers to alleviating drug shortages are regulations.
An Alzheimer’s Cure May Be On the Horizon—But Only With Right-Sized Regulations
The FDA could and should be more open-minded in evaluating the evidence in its drug approval decisions.